These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7552139)

  • 21. Congenital erythropoietic porphyria: characterization of murine models of the severe common (C73R/C73R) and later-onset genotypes.
    Bishop DF; Clavero S; Mohandas N; Desnick RJ
    Mol Med; 2011; 17(7-8):748-56. PubMed ID: 21365124
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular genetics of congenital erythropoietic porphyria.
    Desnick RJ; Glass IA; Xu W; Solis C; Astrin KH
    Semin Liver Dis; 1998; 18(1):77-84. PubMed ID: 9516681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interdependence between degree of porphyrin excess and disease severity in congenital erythropoietic porphyria (Günther's disease).
    Freesemann AG; Bhutani LK; Jacob K; Doss MO
    Arch Dermatol Res; 1997 Apr; 289(5):272-6. PubMed ID: 9164637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyria.
    Solis C; Aizencang GI; Astrin KH; Bishop DF; Desnick RJ
    J Clin Invest; 2001 Mar; 107(6):753-62. PubMed ID: 11254675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compound heterozygosity for a premature termination codon and missense mutation in the exon 10 of the uroporphyrinogen III cosynthase gene causes a severe phenotype of congenital erythropoietic porphyria.
    Kang TW; Oh SW; Kim MR; Lee JS; Kim SC
    J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):470-1. PubMed ID: 18647208
    [No Abstract]   [Full Text] [Related]  

  • 26. Two brothers with mild congenital erythropoietic porphyria due to a novel genotype.
    Berry AA; Desnick RJ; Astrin KH; Shabbeer J; Lucky AW; Lim HW
    Arch Dermatol; 2005 Dec; 141(12):1575-9. PubMed ID: 16365260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tuning intracellular homeostasis of human uroporphyrinogen III synthase by enzyme engineering at a single hotspot of congenital erythropoietic porphyria.
    ben Bdira F; González E; Pluta P; Laín A; Sanz-Parra A; Falcon-Perez JM; Millet O
    Hum Mol Genet; 2014 Nov; 23(21):5805-13. PubMed ID: 24925316
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structural, thermodynamic, and mechanistical studies in uroporphyrinogen III synthase: molecular basis of congenital erythropoietic porphyria.
    Fortian A; Castaño D; Gonzalez E; Laín A; Falcon-Perez JM; Millet O
    Adv Protein Chem Struct Biol; 2011; 83():43-74. PubMed ID: 21570665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of the genotype-phenotype relationship in four cases of congenital erythropoietic porphyria.
    To-Figueras J; Badenas C; Mascaró JM; Madrigal I; Merino A; Bastida P; Lecha M; Herrero C
    Blood Cells Mol Dis; 2007; 38(3):242-6. PubMed ID: 17270473
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Atypical Case of Congenital Erythropoietic Porphyria.
    Sudrié-Arnaud B; Legendre M; Snanoudj S; Pelluard F; Bekri S; Tebani A
    Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutational analysis of uroporphyrinogen III cosynthase gene in Iranian families with congenital erythropoietic porphyria.
    Moghbeli M; Maleknejad M; Arabi A; Abbaszadegan MR
    Mol Biol Rep; 2012 Jun; 39(6):6731-5. PubMed ID: 22350154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Allogeneic bone marrow transplantation in congenital erythropoietic porphyria. Gunther's disease].
    Lagarde C; Hamel-Teillac D; De Prost Y; Blanche S; Thomas C; Fischer A; Nordmann Y; Ged C; De Verneuil H
    Ann Dermatol Venereol; 1998 Feb; 125(2):114-7. PubMed ID: 9747227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feline congenital erythropoietic porphyria: two homozygous UROS missense mutations cause the enzyme deficiency and porphyrin accumulation.
    Clavero S; Bishop DF; Giger U; Haskins ME; Desnick RJ
    Mol Med; 2010; 16(9-10):381-8. PubMed ID: 20485863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prenatal diagnosis in congenital erythropoietic porphyria by metabolic measurement and DNA mutation analysis.
    Ged C; Moreau-Gaudry F; Taine L; Hombrados I; Calvas P; Colombies P; De Verneuil H
    Prenat Diagn; 1996 Jan; 16(1):83-6. PubMed ID: 8821859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracellular rescue of the uroporphyrinogen III synthase activity in enzymes carrying the hotspot mutation C73R.
    Fortian A; González E; Castaño D; Falcon-Perez JM; Millet O
    J Biol Chem; 2011 Apr; 286(15):13127-33. PubMed ID: 21343304
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in understanding the pathogenesis of congenital erythropoietic porphyria.
    Di Pierro E; Brancaleoni V; Granata F
    Br J Haematol; 2016 May; 173(3):365-79. PubMed ID: 26969896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prenatal presentation of congenital erythropoietic porphyria: report of two siblings with elevated maternal serum alpha-fetoprotein.
    Lazebnik N; Lazebnik RS
    Prenat Diagn; 2004 Apr; 24(4):282-6. PubMed ID: 15065102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Congenital erythropoietic porphyria: report of a novel mutation with absence of clinical manifestations in a homozygous mutant sibling.
    Ged C; Mégarbané H; Chouery E; Lalanne M; Mégarbané A; de Verneuil H
    J Invest Dermatol; 2004 Sep; 123(3):589-91. PubMed ID: 15304101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic correction of congenital erythropoietic porphyria by retrovirus-mediated gene transfer into Epstein-Barr virus-transformed B-cell lines.
    Moreau-Gaudry F; Mazurier F; Bensidhoum M; Ged C; de Verneuil H
    Blood; 1995 Mar; 85(6):1449-53. PubMed ID: 7888667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Congenital erythropoietic porphyria. A mild variant with low uroporphyrin I levels due to a missense mutation (A66V) encoding residual uroporphyrinogen III synthase activity.
    Warner CA; Poh-Fitzpatrick MB; Zaider EF; Tsai SF; Desnick RJ
    Arch Dermatol; 1992 Sep; 128(9):1243-8. PubMed ID: 1519940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.